Aromatase inhibitors as add-on treatment for men with epilepsy (Q36106781)

12 August 2017

1 reference

title

Aromatase inhibitors as add-on treatment for men with epilepsy (English)

1 reference

12 August 2017

Cynthia Harden

1

1 reference

12 August 2017

Neil J MacLusky

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

123-127

1 reference

Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Testosterone reduces pentylenetetrazole-induced ictal activity of wildtype mice but not those deficient in type I 5alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Sex differences in models of temporal lobe epilepsy: role of testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Aromatase inhibition, testosterone, and seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.123

21 January 2018

Identifiers

DOI

10.1586/14737175.5.1.123

1 reference

12 August 2017

1 reference